Martin Shkreli's Short Position: Martin Shkreli, known as 'Pharma Bro,' has taken a short position against Opendoor Technologies Inc. at $9.36 and plans to conduct a public due diligence campaign to build a bearish case against the company.
Bearish Sentiment on Opendoor: Shkreli has labeled Opendoor as "an obvious short" and has drawn comparisons to his previous successful short call on Newegg Commerce Inc., while other short-sellers like Andrew Left from Citron Research have also criticized Opendoor's financial practices.
NEGG
$60.3255+Infinity%1D
Analyst Views on NEGG
About NEGG
Newegg Commerce, Inc. is a global online retailer for PC hardware, consumer electronics, gaming peripherals, home appliances, automotive and lifestyle technology. The Company also serves businesses' e-commerce needs with marketing, supply chain, and technical solutions in a single platform. It has developed an online marketplace that delivers value to consumers, brands and sellers in the technology products sector. Additionally, the Company's platforms offer a comprehensive suite of e-commerce solutions, including product listing, fulfillment, marketing, customer service and other value-added tools and services. Its core customers include both its business-to-consumer (B2C) customers and its business-to-business (B2B) customers. The Company's B2C Platforms include Newegg.com, Newegg.ca, Newegg Global and Mobile apps. NeweggBusiness.com, its B2B e-commerce platform, offers a full range of information technology, office and industrial products and solutions for various customers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
